Exelixis, Inc. EXEL reported preliminary, unaudited financial results for fiscal year 2025, issued financial guidance for fiscal 2026, and provided a business update. However, the stock is down in pre ...

Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable to perform their roles properly due to suppression by the tumor. A KAIST ...

Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why immunotherapy works for some patients but not others. Two new studies, published ...

Scientists at MIT and Stanford have unveiled a promising new way to help the immune system recognize and attack cancer cells more effectively. Their strategy targets a hidden “off switch” that tumors ...

E. americana has a two-pronged mechanism to topple cancer cells – first, it has a natural affinity for the low-oxygen environment inside solid tumors, so within just 24 hours it had increased its ...

Megan Barnet receives funding from Boehringer Ingelheim, Takeda Pharmaceuticals, and government-funded grants including the NHMRC. Sarah Sasson does not work for, consult, own shares in or receive ...

The terms tumor and cancer can refer to different types of lumps and bumps. But the terms are often confused and misused—by the general public and even health professionals. For instance, doctors can ...

With four FDA-approved oncology indications and trials exploring new uses, tumor treating fields are emerging as a promising therapeutic option for certain patients with cancer. While using ...

In the fight against cancer, an important field of research is the search for safe alternatives to chemotherapy and radiotherapy. These treatments attack both cancer cells and healthy cells, exposing ...

Scientists found that nearly every cancer harbors its own distinct community of microbes – tiny passengers that can influence how tumors start, spread, and respond to treatment, paving the way for a ...

Background: Proton beam therapy (PBT) is increasingly used for pediatric intracranial tumors due to lower long-term radiation-associated toxicities. However, data on late adverse effects, particularly ...

A network dedicated to early phase trials of treatments for children with brain cancer will be phased out. By Nina Agrawal A respected network of hospitals and cancer centers is halting enrollment in ...